00:00It's Benzinga, bringing Wall Street to Main Street.
00:02New Limit, a longevity startup co-founded by Coinbase CEO Brian Armstrong,
00:07raised $435 million in a funding round that closed Friday, according to the Wall Street Journal.
00:14The recent fundraising brings its valuation to $3.1 billion, more than triple its value a year ago.
00:21New Limit focuses on reversing cellular aging through epigenetic reprogramming,
00:25which alters DNA markings to reset cells to a younger state.
00:28The round was led by Founders Fund and included backing from Thrive Capital, Green Oaks, and Quiet Capital,
00:35alongside returning investors Kleiner Perkins and Eli Lilly's venture arm.
00:40The company has no products on the market but plans to begin human trials of its first drug,
00:45targeting alcohol-related liver disease, next year.
00:48Last year, the company raised $130 million at roughly a third of its current valuation.
00:54For all things money, visit Benzinga.com.
Comments